• Services
    • Consulting
    • Feasibility & Site Selection
    • Regulatory Services
    • Medical Writing
    • Study Management
    • Monitoring
    • Medical Monitoring & Ph.vigilance
    • Event Adjudication
    • eDrug Acc. & Compliance
    • Trial Supply Management
    • Data Management & Analytics
    • Biostatistics
    • Quality & Compliance Service
  • Clinical Trials 5.0
    • Genius Wizards
    • Genius CTMS™
    • Genius eTMF™
    • Genius ENGAGE™
    • Genius ROSA™
    • Genius eCEA™
    • Genius DSM™
    • Genius RIBAM™
    • Genius IWRS™
    • Genius VIGILANCE™
    • Genius eSOURCE™
    • Genius eQUAM™
    • Genius AGENDA™
    • Genius eCRF
    • Genius EVA
    • Genius DaMA
    • Genius eDocumentum
    • Genius SiteVAULT
  • Special Trials
    • Investigator Initiated Trials
    • Peri & Post Approval
  • Expertise
  • Careers
  • Contact
  • Company Brochure
  • Home
  • Services
    • Consulting
    • Feasibility & Site Selection
    • Regulatory Services
    • Medical Writing
    • Study Management
    • Monitoring
    • Medical Monitoring & Ph.Vigilance
    • eDrug Acc. & Compliance
    • Trial Supply Management
    • Data Management & Analytics
    • Biostatistics
    • Quality & Compliance Service
  • Clinical Trials 5.0
    • Genius Wizards
    • Genius CTMS™
    • Genius eTMF™
    • Genius ENGAGE™
    • Genius ROSA
    • Genius eCEA™
    • Genius DSM™
    • Genius RIBAM™
    • Genius IWRS™
    • Genius VIGILANCE™
    • Genius eSOURCE™
    • Genius eQUAM™
    • Genius AGENDA™
    • Genius eCRF
    • Genius EVA
    • Genius DaMA
    • Genius eDocumentum
    • Genius SiteVAULT
  • Investigator’s Initiated Trials (IITs)
  • Peri & Post
  • Expertise
  • Careers
  • Contact
  • Company Brochure
Exom Group
  • Home
  • About
  • App Privacy Policy
  • Automated PRICK Test Feasibility
  • Careers
    • Project Manager | Clinical Operations
    • Study Site Monitor (CRA) – Germany
    • Study Site Monitor | Clinical Operations
  • Clinical Trials 5.0
  • Contact
  • Cookie Policy
  • Exom – Company Brochure
  • Expertise
  • Front-End Developer
  • Genius DaMA
  • Genius eCRF
  • Genius eDocumentum
  • Genius EVA
  • Genius SiteVAULT
  • Genius Suite®
    • Genius AGENDA™
    • Genius CTMS™
    • Genius DSM™
    • Genius E-TMF™
    • Genius eCEA™
    • Genius ENGAGE™
    • Genius ePRO™
    • Genius eQUAM™
    • Genius eSOURCE™
    • Genius INSIGHT™
    • Genius IWRS™
    • Genius LINGO™
    • Genius RIBAM™
    • Genius ROSA
    • Genius VIGILANCE™
  • Genius Wizards
  • Home
  • Investigator’s Initiated Trials (IITs)
  • Legal
  • Legal Notes
  • Newsletter
  • Newsletter Subscription Confirmation
  • Newsletter Unsubscribe
  • Peri & Post
  • Privacy
  • Request a Live-Demo
  • Services
    • Biostatistics
    • Consulting
    • Data Management
    • e-Drug Accountability & Compliance
    • Event Adjudication
    • Feasibility & Site Selection
    • Medical Monitoring & Pharmacovigilance
    • Medical Writing
    • Monitoring
    • Quality & Compliance Service
    • Regulatory Services
    • Study Management
  • Survey
  • Terms of use
  • Trial Supply Management
  • Articles
    • Case Study
    • Clinical Trial News
    • Genius Suite
      • Genius Engage
    • Luigi Visani
    • Meeting & Conference
  • Company News
  • Uncategorized
  • Upcoming Events
Select Page

Luigi Visani, Exom’s CEO will be speaking at the mHealth for Clinical Trials Europe 2018, in London April 17, 2018

Apr 13, 2018 | Articles, Luigi Visani, Meeting & Conference

On April 17th, 2018 , Luigi Visani, CEO of Exom Group, will be a speaker at the mHealth for Clinical Trials Europe 2018 , in London. The event will bring together the leaders and biggest promoters in the space for a comprehensive and open discussion on how to...

Luigi Visani, Exom’s CEO will be speaking at the 5th National Meeting on the no-profit Clinical Research, organized by FADOI

Mar 12, 2018 | Articles, Luigi Visani, Meeting & Conference

Rome, March 22nd, 2018 On March 22nd, Luigi Visani, CEO of Exom Group, will be among the speakers of the congress organized by the Italian Federation of the Internal Medicine Hospital Executives’ Associations (FADOI,) that will be dealing with the no-profit...

Luigi Visani, Exom’s CEO has been speaker at two scientific events, in Warsaw (Poland) and Milano (Italy)

Dec 6, 2017 | Articles, Clinical Trial News, Genius Engage, Genius Suite, Luigi Visani, Meeting & Conference

On November 14th, Luigi Visani, CEO of Exom Group, has been among the speakers of the seminar organized by the Polish Association of GCPs Professionals entitled “The e-solutions in medicine, such as eHR and eICF, will revolutionize clinical research ? “ and  made a...

Recent News

  • Geremy Project: Exom is part of a project to find a genetic cure for cardiomyopathy

  • Genius vENGAGE – Remote Verbal Consent

  • The Clinical Trial part of “Best of ASCO 2022”

  • Clinscience invests in Texas-based Agati Group

  • GHP Global Excellence Awards 2022 – Winner

Receive our Newsletter

* indicates required

Please select all the ways you would like to hear from Exom Group Srl:


You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please click here.


Categories

Archives

Services

  • Consulting
  • Feasibility & Site Selection
  • Regulatory Services
  • Medical Writing
  • Study Management
  • Monitoring
  • Medical Monitoring & Pharmacovigilance
  • Event Adjudication
  • e-Drug Accountability & Compliance
  • Data Management & Analytics
  • Biostatistics
  • Quality & Compliance Service

Work with us!

See our open positions

Clinical Trials 5.0

  • Genius Wizards
  • Genius CTMS™
  • Genius eTMF™
  • Genius ENGAGE™
  • Genius ROSA
  • Genius eCEA™
  • Genius DSM™
  • Genius RIBAM™
  • Genius IWRS™
  • Genius VIGILANCE™
  • Genius eSOURCE™
  • Genius eQUAM™
  • Genius AGENDA™

Special Trials

  • Investigators initiated trials
  • Peri & Post Approval

 

Receive our Newsletter

* indicates required

Please select all the ways you would like to hear from Exom Group Srl:


For information about our privacy practices, please click here.


News

  • Geremy Project: Exom is part of a project to find a genetic cure for cardiomyopathy

  • Genius vENGAGE – Remote Verbal Consent

Exom Group Srl

Viale F. Restelli 3/1
20124 Milano
+39 02-36725581
info@exomgroup.com
P.I. IT08742520961

  • Privacy Policy
  • Cookie Policy
  • Copyright © 2022 Exom Group. All rights reserved
  • Terms of Use
  • Legal Notes

Powered by Seo Kappa